JPMorgan Starts Definium Therapeutics Inc (DFTX) at Overweight Oct 9, 2026 05:11AM
3 high-conviction SMID-cap biotech stocks to buy: Jefferies Oct 1, 2026 03:00PM
Oppenheimer sees positive outlook for psychedelics after FDA hearing Sep 16, 2026 05:31AM
Definium Therapeutics Inc (DFTX) PT Raised to $78 at Canaccord Sep 15, 2026 07:36AM
H.C. Wainwright Reiterates Buy Rating on Definium Therapeutics Inc (DFTX) Sep 15, 2026 07:20AM


Sep 14, 2026 09:36AM Definium Therapeutics Inc (DFTX) PT Raised to $67 at Stifel
Sep 14, 2026 06:58AM Definium Therapeutics (DFTX) Halted, News Pending
Sep 2, 2026 08:50AM Stifel Reiterates Buy Rating on Definium Therapeutics Inc (DFTX)
Aug 31, 2026 03:13PM Definium Therapeutics (DFTX) call put ratio 1 call to 1.9 puts as share price down 3.6%
Aug 31, 2026 09:25AM Stifel Reiterates Buy Rating on Definium Therapeutics Inc (DFTX)
Aug 31, 2026 05:16AM Stifel on Definium Therapeutics (DFTX) Post Mgmt Dinner Meet: 'Confident Overall in Regulatory/Commercial Dynamics'
Aug 17, 2026 04:53PM BofA Securities Starts Definium Therapeutics Inc (DFTX) at Buy
Aug 13, 2026 06:49AM Definium Therapeutics Inc (DFTX) PT Raised to $64 at Canaccord
Aug 6, 2026 04:19PM Mind Medicine (DFTX) Misses Q2 EPS by 144c
Jul 27, 2026 06:55AM Wells Fargo sees psychedelics market reaching $11B by 2035
Jul 24, 2026 07:50AM Definium Therapeutics Inc (DFTX) PT Raised to $73 at Piper Sandler Ahead For DT120
Jul 16, 2026 07:01AM Definium Therapeutics launches GAD education program for providers
Jul 7, 2026 04:32PM Definium Therapeutics Inc (DFTX) PT Raised to $60 at Stifel
Jun 30, 2026 06:48AM Definium Therapeutics Inc (DFTX) PT Lowered to $58 at Canaccord
Jun 23, 2026 07:24AM Definium Therapeutics Inc (DFTX) PT Raised to $50 at Needham
Jun 22, 2026 11:31AM Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer
Jun 22, 2026 10:20AM Definium Therapeutics Inc (DFTX) PT Raised to $52 at Leerink
May 8, 2026 06:32AM RBC Capital Reiterates Outperform Rating on Definium Therapeutics Inc (DFTX), sees favorable set up
May 7, 2026 04:20PM Definium Therapeutics, Inc. (DFTX) Misses Q1 EPS by 23c
Apr 24, 2026 08:03AM Definium Therapeutics (DFTX) Reiterated at Buy by Stifel After Analyst Day
Apr 24, 2026 06:41AM H.C. Wainwright Reiterates Buy Rating on Definium Therapeutics Inc (DFTX)
Apr 23, 2026 09:15AM Piper Sandler Reiterates Overweight Rating on Definium Therapeutics Inc (DFTX)
Apr 22, 2026 04:15PM Definium Therapeutics updates DT120 clinical trials and commercial plans
Apr 20, 2026 06:08AM Psychedelic stocks soar after Trump signs executive order to fast-track treatments
Apr 16, 2026 04:15PM Stifel Starts Definium Therapeutics Inc (DFTX) at Buy
Apr 16, 2026 11:53AM White House Prepares Order On Ibogaine Psychedelic - CBS
Apr 10, 2026 01:54AM Piper Sandler Starts Definium Therapeutics Inc (DFTX) at Overweight
Mar 31, 2026 07:01AM Definium study shows anxiety disorder prevalence rose to 6.6% in 2023
Feb 24, 2026 09:19AM Wolfe Research Starts Definium Therapeutics Inc (DFTX) at Outperform, Top Pick
Feb 2, 2026 07:24AM Definium Therapeutics (DFTX) Reiterated at Overweight by Cantor Fitzgerald
Jan 30, 2026 01:02AM Jefferies Starts Definium Therapeutics Inc (DFTX) at Buy
Jan 23, 2026 06:09AM Definium Therapeutics Inc (DFTX) PT Raised to $36 at RBC Capital
Jan 20, 2026 07:01AM Definium Therapeutics launches educational campaign on LSD research
Jan 13, 2026 07:01AM Definium Therapeutics delays ticker change to DFTX until January 15